期刊文献+

肿瘤分子标志的发现和验证:问题和策略探讨

Tumor Biomarker Identification and Validation: Problems and Strategies
下载PDF
导出
摘要 1现状和问题分析 分子标志在肿瘤筛查和诊断、预测疗效、复发、转移及预后方面呈现巨大潜力。同时,许多分子标志本身也是治疗肿瘤的药物靶点。这一认识很大程度归功于我们对肿瘤在分子水平上认识的极大丰富和高通量芯片新技术的不断产生和更新。
作者 李雨晨 宋韦
出处 《中国肺癌杂志》 CAS 2010年第12期1085-1088,共4页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 肿瘤标志物 诊断 Lung neoplasms Tumor biomarker Diagnosis
  • 相关文献

参考文献8

  • 1Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000, 100(1): 57-70.
  • 2Hayes DE Bast RC, Desch CE, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Nail Cancer Inst, 1996, 88(20): 1456-1466.
  • 3Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 2001, 19(6): 1865-1878.
  • 4Thomson DM, Krupey J, Freedman SO, et al. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Nail Acad Sci USA, 1969, 64(1): 161-167.
  • 5Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N EnglJ Med, 1978, 299(17): 926-930.
  • 6Subramanian J, Simon R. Gene expression-based prognostic signature in lung cancer: ready or clinical use.J Nail Cancer Inst, 2010, 102(7): 464-474.
  • 7RansohoffDF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer, 2004, 4(4): 309-313.
  • 8McShane LM, Altman DG, Sauerbrei W, et al. Keporting recommendations for tumor marker prognostic studies. J Clin Oncol, 2005, 23(36): 9067-9071.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部